Concepedia

Andrew Dawdy

AD

8

Publications

321

Citations

8

H-Index

2002

Active since

Affiliations

Pfizer (United States)(Current)

University of Virginia

National Institute of Standards and Technology

United States Food and Drug Administration

Agilent Technologies (United States)

Andrew Dawdy is an author at Pfizer (United States) specializing in management, knowledge discovery, and quantitative management.

ORCID

Top concepts

Publications per year

2002–2023

8

Publications

8

<i>O</i>-GlcNAcylation of master growth repressor DELLA by SECRET AGENT modulates multiple signaling pathways in<i>Arabidopsis</i>

Rodolfo Zentella, Jianhong Hu, Wen‐Ping Hsieh et al. · Genes & Development · 2016 · 124 citations · Full text

O-Linked β-N-Acetylglucosamine (O-GlcNAc) Regulates Emerin Binding to Barrier to Autointegration Factor (BAF) in a Chromatin- and Lamin B-enriched “Niche”

Jason M. Berk, Sushmit Maitra, Andrew Dawdy et al. · Journal of Biological Chemistry · 2013 · 42 citations · Full text

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2021 · 39 citations · Full text

Oligonucleotide mapping via mass spectrometry to enable comprehensive primary structure characterization of an mRNA vaccine against SARS-CoV-2

Brian Gau, Andrew Dawdy, Hanliu Leah Wang et al. · Scientific Reports · 2023 · 34 citations · Full text

Site-Specific Phosphorylation of the DNA Damage Response Mediator Rad9 by Cyclin-Dependent Kinases Regulates Activation of Checkpoint Kinase 1

Carla M. C. Abreu, Ramesh Kumar, Danielle S. Hamilton et al. · PLoS Genetics · 2013 · 27 citations · Full text

Rows per page

1–5 of 8